Prof. Dr. Stefan Pöhlmann

Further involvements

• 28/03/2023

  • Poster
  • P 211

  Characterization of extracellular vesicles from various body fluids that show broad antiviral activities

   Host cell factors and modulation, Innate immunity
• 28/03/2023

  • Poster
  • P 327

  Glycoprotein K8.1 is critical for liver tropism of Kaposi's sarcoma-associated herpesvirus (KSHV) in the nonhuman primate marmoset infection model

   Viral pathogenesis and persistence
• 28/03/2023

  • Poster
  • P 163

  Evidence that SEC61B is required for Marburg virus glycoprotein processing and function

   Antiviral therapy and resistance, Host cell factors and modulation
• 28/03/2023

  • Poster
  • P 127

  Recombinant systems and reporter viruses for primate Simplexviruses

   Emerging viruses and zoonosis, Viral pathogenesis and persistence
• 28/03/2023

  • Poster
  • P 141

  Host cell entry efficiency and neutralization sensitivity of SARS-CoV-2 lineage XBB.1 and XBB.1.5

   Epidemiology and public health
• 28/03/2023

  • Poster
  • P 242

  Antigenic distances between emerging SARS-CoV-2 variants of concern

   Emerging viruses and zoonosis, SARS-CoV-2
• 28/03/2023

  • Poster
  • P 269

  TMPRSS2 is essential for SARS-CoV-2 Beta and Omicron infection in mice

   SARS-CoV-2, Virus receptors and entry
• 28/03/2023

  • Poster
  • P 174

  Shiftless multimerization is required for inhibition of HIV-1 infection

   Host cell factors and modulation, Innate immunity
• 29/03/2023

  13:45 – 14:00 12 Min. 3 Min.

  • Abstract Talk
  • O 068

  Influenza A virus defective interfering particles as antiviral agents

   Antiviral therapy and resistance, Viral vectors and gene therapy
• 31/03/2023

  11:00 – 11:15 12 Min. 3 Min.

  • Abstract Talk
  • O 116

  An MCMV-based vaccine expressing full-length parental SARS-CoV-2 spike provides long-lived and broad protection against SARS-CoV-2 variants in mice

   SARS-CoV-2, Vaccines